Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PABPC1 | P11940 | 3/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | CASP1 | P29466 | 2/20 | 0.55 |
| ▸ | CASP7 | P55210 | 2/20 | 0.55 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 7/20 | 0.54 |
| ▸ | MEN1 | O00255 | 4/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | APEX1 | P27695 | 2/20 | 0.54 |
| ▸ | MAOA | P21397 | 3/20 | 0.53 |
| ▸ | NPC1 | O15118 | 6/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.47 |
| ▸ | RAB9A | P51151 | 5/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | PTK2B | Q14289 | 2/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | CDC25B | P30305 | 1/20 | 0.44 |
| ▸ | PTPRC | P08575 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29827450 | 1.00 | PABPC1 (0.55) | PABPC1CYP3A4CASP1CASP7DNMT1 | |
| SCHEMBL732391 | 0.88 | ALDH1A1 (0.44) | PABPC1CYP3A4CASP1CASP7DNMT1 | |
| SCHEMBL28357765 | 0.77 | TYMS (0.52) | MAPTMEN1KMT2AAPEX1MAOA | |
| SCHEMBL22798938 | 0.76 | NPC1 (0.38) | MAPTMEN1KMT2AMAOANPC1 | |
| SCHEMBL23496967 | 0.76 | MAPT (0.43) | PABPC1CYP3A4MAPTMEN1KMT2A | |
| SCHEMBL17228822 | 0.76 | MAOA (0.42) | MAOASMN1; SMN2KDM4EMAOBCDC25B | |
| SCHEMBL29029657 | 0.76 | PARP1 (0.53) | CYP3A4CASP1CASP7MAPTMEN1 | |
| SCHEMBL13854898 | 0.76 | ALDH1A1 (0.57) | CASP1CASP7MAPTMEN1KMT2A | |
| SCHEMBL28057086 | 0.74 | NPC1 (0.59) | DNMT1MAPTNPC1SMN1; SMN2RAB9A | |
| SCHEMBL460367 | 0.73 | MAOA (0.56) | PABPC1CYP3A4CASP1CASP7DNMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060147737-A1 | Reactive colorant compounds and polymeric materials copolymerized therewith | EASTMAN CHEMICAL COMPANY | 2006-07-06 | — | — | US | claimed |
| US-6776930-B2 | POLYMER BONDED TO DYE | EASTMAN KODAK COMPANY | 2004-08-17 | — | — | US | claimed |
| EP-0747036-B1 | A method of coloring hair with, and hair coloring compositions comprising, sulfo-containing water dispersible colored polymers | CLAIROL INC (US) | 2003-05-07 | — | — | EP | claimed |
| US-20010023938-A1 | Polymer bonded to dye | ALLEN MAX (US) | 2001-09-27 | — | — | US | claimed |
| US-6197223-B1 | REACTING DIACIDIC MONOMER HAVING FORMULA H--A--H, COMPRISING 1 TO 100 MOLE % OF LIGHT-ABSORBING MONOMER HAVING A LIGHT ABSORPTION MAXIMUM BETWEEN 300 NM AND 1200 NM AND 99-0 MOLE % OF A NON-LIGHT ABSORBING MONOMER WITH ORGANIC COMPOUND | EASTMAN CHEMICAL COMPANY | 2001-03-06 | — | — | US | claimed |
| EP-0869765-A1 | AQUEOUS NAIL COATING COMPOSITION CONTAINING COPOLYMERIZED COLORANTS | EASTMAN CHEMICAL COMPANY (US) | 1998-10-14 | — | — | EP | claimed |
| WO-1997024102-A1 | AQUEOUS NAIL COATING COMPOSITION CONTAINING COPOLYMERIZED COLORANTS | EASTMAN CHEMICAL COMPANY (US) | 1997-07-10 | — | — | WO | claimed |
| EP-0747036-A2 | A method of coloring hair with, and hair coloring compositions comprising, sulfo-containing water dispersible colored polymers | Bristol-Myers Squibb Company (US) | 1996-12-11 | — | — | EP | claimed |
| EP-0445926-A2 | Organic materials having sulfonamido linked poly(oxyalkylene) moieties and their preparation | MILLIKEN RESEARCH CORPORATION (US) | 1991-09-11 | — | — | EP | claimed |
| US-20240239730-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2024-07-18 | — | — | US | disclosed |
| EP-4389765-A2 | METHODS OF PERMEABILIZING THE BLOOD BRAIN BARRIER | University of Southern California (US) | 2024-06-26 | — | — | EP | disclosed |
| US-20240197891-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2024-06-20 | — | — | US | disclosed |
| EP-4374929-A2 | METHODS AND DEVICES FOR USING ISOPERILLYL ALCOHOL | University of Southern California (US) | 2024-05-29 | — | — | EP | disclosed |
| US-11970436-B2 | Pharmaceutical compositions comprising monoterpenes | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2024-04-30 | — | — | US | disclosed |
| EP-0445926-B1 | Organic materials having sulfonamido linked poly(oxyalkylene) moieties and their preparation | MILLIKEN RES CORP (US) | 1996-08-21 | — | — | EP | disclosed |
| EP-0555361-B1 | POWDER COLORANT COMPOSITIONS AND PROCESS FOR THE PREPARATION THEREOF | EASTMAN CHEM CO (US) | 1995-01-11 | — | — | EP | disclosed |
| US-5240464-A | Organic materials having sulfonamido linked poly(oxyalkylene) moieties and their preparation | MILLIKEN RESEARCH CORPORATION (US) | 1993-08-31 | — | — | US | disclosed |
| EP-0555361-A1 | POWDER COLORANT COMPOSITIONS AND PROCESS FOR THE PREPARATION THEREOF. | EASTMAN KODAK CO (US) | 1993-08-18 | — | — | EP | disclosed |
| WO-1992007913-A1 | POWDER COLORANT COMPOSITIONS AND PROCESS FOR THE PREPARATION THEREOF | EASTMAN KODAK COMPANY (US) | 1992-05-14 | — | — | WO | disclosed |
| EP-0445926-A2 | Organic materials having sulfonamido linked poly(oxyalkylene) moieties and their preparation | MILLIKEN RESEARCH CORPORATION (US) | 1991-09-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239730-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES | SQLE, DHPS, GGPS1 | PABPC1 2628/4885CYP3A4 23/4885CASP1 1320/4885 |
| US-20240197891-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES | PLIN3, PLIN5, PLIN1 | PABPC1 2490/4885CYP3A4 375/4885CASP1 1824/4885 |
| US-11970436-B2 | Pharmaceutical compositions comprising monoterpenes | SQLE, DHPS, GGPS1 | PABPC1 2628/4885CYP3A4 23/4885CASP1 1320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.